The FDA is proposing the removal of phenylephrine, a popular nasal decongestant, in oral form from over-the-counter use. Here ...

Pet store Pet Evolution and wellness company Saint have signed 10-year leases for a total of 3,100 square feet at MAG ...

I'm not saying the stocks on this list can generate those kinds of returns. But they are trading at discounted valuations, and investing $5,000 into them can be a good move. Prudent investors will ...

Let us look at five large biotech and generic drug companies, NVO, GILD, MRNA, VTRS and TEVA, which are gearing up for their ...

Deadly fungi including Candida auris have been spreading. Gilead and Merck are two pharma stocks worth owning amidst fungal ...

The Sunny View community found a beacon of hope at McGuinn’s Store in the days after Tropical Storm Helene.  In the storm’s ...

the therapeutics-focused corporate venture fund of Merck & Co. (NYSE: MRK). The company now has more than $300 million in cash and is "well-positioned to prosecute several opportunities to expand ...

RAHWAY, N.J. & CAMBRIDGE, Mass. - Merck (NYSE: MRK) and Moderna , Inc. (Nasdaq: NASDAQ:MRNA) have announced the commencement of a Phase 3 clinical trial, INTerpath-009, to evaluate the efficacy of ...

This year, pharmaceutical giant Merck (NYSE: MRK) is it: The drugmaker's shares are down by 2% in 2024 while the broader S&P 500 is up by 21%. Even when we zoom out, Merck hasn't performed ...

Merck & Co., Inc. (NYSE:MRK), a global leader in the biopharmaceutical industry, continues to navigate a complex landscape of opportunities and challenges as it solidifies its position in key ...

Merck's recently approved vaccine, however, gives Pfizer some major competition. The shot, called Capvaxive, protects against bacterial strains that cause about 84% of cases of adult pneumoccocal ...